Dimitris Karagiannis

Years Active: 2019-2023
Publications (10 Years): 5

This page only lists publications with an associated author ORCID identifier.

Publications

Dimitris Karagiannis, Warren Wu, Albert Li, Makiko Hayashi, Xiao Chen, Michaela Yip, Vaibhav Mangipudy, Xinjing Xu, Francisco J Sánchez-Rivera, Yadira M Soto-Feliciano, Jiangbin Ye, Thales Papagiannakopoulos, Chao Lu
Metabolic Reprogramming by Histone Deacetylase Inhibition Selectively Targets NRF2-activated tumors. bioRxiv : the preprint server for biology (2023)
Dimitris Karagiannis, Warren Wu, Albert Li, Makiko Hayashi, Xiao Chen, Michaela Yip, Vaibhav Mangipudy, Xinjing Xu, Francisco J Sánchez-Rivera, Yadira M Soto-Feliciano, Jiangbin Ye, Thales Papagiannakopoulos, Chao Lu
Metabolic Reprogramming by Histone Deacetylase Inhibition Selectively Targets NRF2-activated tumors. bioRxiv : the preprint server for biology (2023)
Dimitris Karagiannis, Theodoros Rampias
Cancer Evolution in Precision Medicine Era. Cancers 14 (8) (2022)
Dimitris Karagiannis, Theodoros Rampias
HDAC Inhibitors: Dissecting Mechanisms of Action to Counter Tumor Heterogeneity. Cancers 13 (14) (2021)
Theodoros Rampias, Dimitris Karagiannis, Margaritis Avgeris, Alexander Polyzos, Antonis Kokkalis, Zoi Kanaki, Evgenia Kousidou, Maria Tzetis, Emmanouil Kanavakis, Konstantinos Stravodimos, Kalliopi N Manola, Gabriel E Pantelias, Andreas Scorilas, Apostolos Klinakis
The lysine-specific methyltransferase KMT2C/MLL3 regulates DNA repair components in cancer. EMBO reports 20 (3) (2019)

Dimitris Karagiannis.css-eqlu8i{font-size:small;padding-left:4px;}